Eligibility usually depends on what the product does
Injection site pain, swelling, or redness: rotate sites within the target area (1-2 inches)
dulaglutide: Trulicity), oral GLP-1 (Rybelsus), non-GLP-1 options (metformin, topiramate, bupropion, naltrexone, orlistat)
In a phase 2a proof-of-concept study in RA patients, ABBV-337 exhibited statistically significant better response than adalimumab alone at week 12 [209]
and these tend to resolve quickly
People who have a deficit may benefit from vitamin B12 treatments to boost energy, enhance memory, and improve their quality of life